Loading
Every time a team of specialists meets to plan a patient's treatment, they would have to record whether a trial exists for that patient and, if so, why it was or was not offered.
Multidisciplinary tumour boards and molecular tumour boards add a required structured field to their recommendation: matched trials considered (with identifiers), offered yes/no, and reason if not. A trial coordinator pre-populates the field from a matching tool before the meeting. The field is auditable and the offer rate reported quarterly by service.
Shares AI trial matching & clinical decision support, Trials enrol too few, too slowly.
Shares AI trial matching & clinical decision support, Trials enrol too few, too slowly.
Shares AI trial matching & clinical decision support, Trials enrol too few, too slowly.
Shares AI trial matching & clinical decision support, Trials enrol too few, too slowly.
Shares AI trial matching & clinical decision support, Trials enrol too few, too slowly.
Shares AI trial matching & clinical decision support, Trials enrol too few, too slowly.
Shares Trials enrol too few, too slowly, Memorial Sloan Kettering Cancer Center.